Is 6.6 a Good A1C? What Your Result Really Means

An A1C of 6.6% places you just over the 6.5% threshold that most guidelines use to diagnose type 2 diabetes, which makes it a result that demands attention but not panic. Whether it qualifies as “good” depends heavily on your starting point, your age, your overall health, and what your doctor has set as your personal target. For someone recently diagnosed who started at 9%, reaching 6.6% is a genuine achievement. For someone without a prior diabetes diagnosis, 6.6% is the number that changes the conversation entirely.

What 6.6% Means in Everyday Blood Sugar

A1C measures how much glucose has attached to your red blood cells over their roughly 120-day lifespan. Glucose bonds to hemoglobin slowly and continuously, so the percentage reflects a weighted average of your blood sugar over the past two to three months, with more recent weeks counting more heavily than earlier ones.¹ Researchers established a reliable formula to convert A1C into estimated average glucose, and at 6.6%, that works out to roughly 143 mg/dL.² That is a number you might see on a fasting glucose test that would make your doctor frown but not reach for a prescription pad. As a two-to-three-month average, though, it tells you that your blood sugar is spending a meaningful amount of time elevated.

Where 6.6% Sits on the Diagnostic Scale

The standard diagnostic cutoffs divide A1C results into three zones: below 5.7% is considered normal, 5.7% to 6.4% falls in the prediabetes range, and 6.5% or above meets the criteria for diabetes. An A1C of 6.6% crosses that diabetes line, though just barely. This threshold was chosen because it marks the level at which the risk of certain complications, particularly damage to the small blood vessels in the eyes, starts to climb more steeply.³

If this is your first time seeing a 6.6% result and you haven’t been diagnosed with diabetes before, your doctor will likely want to confirm it with a repeat test or a fasting glucose measurement. A single A1C reading can be influenced by lab variability and individual biological factors, so diagnosis usually isn’t made on one test alone.

What the Major Guidelines Say About Targets

Here is where “good” gets complicated, because the two most influential sets of diabetes guidelines in the United States don’t entirely agree. The American Diabetes Association and the European Association for the Study of Diabetes generally recommend keeping A1C at or below 7.0% for most adults with diabetes. The American Association of Clinical Endocrinologists and American College of Endocrinology set a tighter target of 6.5% or below.⁴ Both organizations stress that targets should be adjusted based on individual circumstances, including age, how long someone has had diabetes, and what medications they’re taking.

The American College of Physicians reviewed multiple national and international guidelines and found broad agreement that targets should be personalized rather than applied rigidly.⁵ Under the more lenient ADA standard, 6.6% is well within the target range. Under the stricter AACE guideline, it’s just barely above the goal. Either way, you are in a different clinical situation than someone running an A1C of 8% or 9%.

Complication Risk at This Level

The concern with any elevated A1C is what it does to your body over years and decades. The good news for someone sitting at 6.6% is that the relationship between A1C and complications isn’t a smooth upward slope. Research in people with type 2 diabetes has identified what appear to be threshold effects: below about 7.0% for large-vessel problems like heart attack and stroke, and below about 6.5% for small-vessel damage to the eyes, kidneys, and nerves, the risk doesn’t change much. Above those levels, however, each additional percentage point of A1C is associated with roughly a 38-40% increase in risk for vascular complications and death.⁶

At 6.6%, you’re right at that inflection point for microvascular risk. A meta-analysis looking specifically at the diagnostic cutoff found that the pooled prevalence of retinopathy jumped from about 2.3% in people with A1C between 6.0% and 6.4% to about 7.8% at A1C of 6.5% and above.³ Nephropathy rates showed a similar pattern, rising from about 10% in the prediabetes A1C range to about 17% at or above 6.5%. So 6.6% places you on the lower end of the diabetes risk range, but you’ve crossed a line where the probability of these problems starts to tick upward.

Cardiovascular Risk Starts Before 6.5%

Heart and blood vessel disease deserves its own mention because the risk doesn’t wait neatly for the diabetes threshold. A large Canadian population study of more than 600,000 adults without a diabetes diagnosis found that people with A1C in the 6.0% to 6.4% range already had a meaningfully higher risk of cardiovascular hospitalization compared to those with lower A1C levels. Men in that range had a 38% higher risk of cardiovascular hospitalization, and women had a 17% higher risk. At 6.5% and above, the risk climbed to 79% higher in men and 51% higher in women.⁷

A Japanese cohort study added an interesting wrinkle: the relationship between A1C and cardiovascular disease in people without known diabetes wasn’t linear. People with very low A1C (below 5.0%) also had elevated risk, while those in the 5.5% to 6.4% range showed no significant increase compared to the reference group. Risk rose sharply only at 6.5% and above.⁸ These population-level findings suggest that 6.6% is a zone where cardiovascular vigilance matters, even though the sharpest increases in risk tend to come at higher A1C values.

When a Higher Target Is Actually Better

For older adults and people with multiple chronic conditions, pushing A1C down to 6.5% or below can actually cause more harm than the elevated blood sugar itself. The main danger is hypoglycemia, or low blood sugar, which in elderly patients is linked to falls, heart rhythm problems, cognitive changes, and even death.⁹ Older adults are especially vulnerable because their bodies are less able to recognize and correct low blood sugar, and they are often taking multiple medications that can interact unpredictably.

For this reason, clinical experts recommend relaxing A1C goals in older and frail patients as part of individualized care.¹⁰ An A1C of 7.5% or even 8.0% might be the right target for someone in their 80s with heart disease and cognitive decline, because the long-term benefits of tight glucose control may not materialize in their remaining lifespan, while the short-term dangers of low blood sugar are immediate and severe.¹¹ For a healthy 45-year-old with decades ahead, 6.6% warrants active management. For a frail 82-year-old on insulin, 6.6% might already be tighter than it should be.

Factors That Can Make Your A1C Misleading

A1C is a useful but imperfect tool, and at 6.6%, where so much depends on which side of the 6.5% line you fall, the imperfections matter more than usual. Several conditions can push the number up or down independent of your actual blood sugar levels.

Iron deficiency is one of the most common culprits. When your body is low on iron, the structure of hemoglobin changes in ways that accelerate glucose attachment, which can artificially inflate your A1C.¹² Someone with untreated iron-deficiency anemia might test at 6.6% when their true glucose exposure would produce a lower number. Anything that changes how long red blood cells survive can also throw the reading off, since A1C depends on glucose accumulating over the cell’s full lifespan. Conditions that shorten red blood cell life, like certain hemoglobin variants or chronic kidney disease, tend to make A1C read falsely low. Conditions that lengthen it, like iron deficiency, push it up.¹³

Racial and Ethnic Differences

One of the more troubling findings in A1C research is that the test doesn’t behave the same way across all populations. A systematic review and meta-analysis found that, at the same blood glucose levels, Black individuals had A1C readings about 0.26 percentage points higher than White individuals. Asian individuals showed a similar gap of about 0.24 points higher, and Latino individuals were about 0.08 points higher.¹⁴ These differences persisted even after adjusting for actual glucose levels and other health factors.¹⁵

Part of the explanation may be genetic. A common variant in the G6PD gene, carried by about 11% of African Americans, is associated with a drop in A1C of roughly 0.8 percentage points per allele in men who carry it. Researchers estimate this variant alone may cause about 650,000 African American adults with actual diabetes to go undiagnosed when screening relies on A1C.¹⁶ The practical upshot: if you’re a Black man with a G6PD variant reading at 6.6%, your actual glucose exposure could be worse than the number suggests. If you’re someone whose biology pushes A1C higher independent of glucose, a 6.6% might overstate the problem. This is exactly why good clinical care doesn’t treat the number in isolation.

What A1C Hides About Your Day-to-Day Glucose

Two people can share an A1C of 6.6% while living very different metabolic lives. One might have blood sugar that hovers steadily around 140 mg/dL all day. The other might swing between 70 mg/dL and 250 mg/dL, with the highs and lows averaging out to the same result. The A1C doesn’t distinguish between them, but the second pattern, with its wild variability, may carry its own risks.

Continuous glucose monitors have made it possible to measure “time in range,” the percentage of the day your glucose stays between 70 and 180 mg/dL. Researchers have found that A1C and time in range are correlated, but not as tightly as you might expect. At a given A1C, the actual time in range can vary enormously. One study found that at an A1C of 7.5%, the predicted time in range was about 56%, but the true value could range anywhere from 34% to 78%.¹⁷ At a lower A1C like 6.6%, you’d expect a higher time in range, but the same spread applies proportionally.¹⁸

Some researchers have argued that time in range should be elevated to a primary outcome measure in diabetes research because A1C can miss meaningful differences in how well a treatment works day to day.¹⁹ If you have access to a continuous glucose monitor, the data it generates paints a much more detailed picture than A1C alone. Your doctor may use both numbers together to fine-tune your treatment.

Bringing 6.6% Down

If you and your doctor decide that 6.6% is higher than your personal target, the encouraging reality is that this level is very responsive to intervention. You’re not starting from a position that requires aggressive medication. Depending on the circumstances, lifestyle changes alone may be enough to move the needle.

A randomized trial found that a low-carbohydrate diet produced an A1C reduction of about 0.23 percentage points more than a usual diet over six months in people who already had or were at risk for type 2 diabetes.²⁰ That’s enough to potentially bring 6.6% below the diabetes threshold. Exercise adds to the effect: a trial comparing aerobic training, resistance training, and the combination found that doing both together lowered A1C by about half a percentage point compared to a control group.²¹

Weight loss is another powerful lever. A small study of people with recently diagnosed type 2 diabetes found that eight out of ten participants who completed an exercise and weight-loss program achieved at least partial remission, with the average A1C dropping from 6.8% to 6.2%.²² A larger retrospective study of a structured program combining calorie restriction, coaching, and customized fitness saw average A1C fall from 9.0% to 7.1%.²³ And a 12-week low-calorie program using meal replacements and digital coaching reduced A1C by about 1.0 percentage point on average.²⁴

When lifestyle changes aren’t enough on their own, medication enters the picture. Metformin is the most common first-line drug, and combining it with a second medication from the start has been shown to be more effective at hitting A1C targets than metformin alone.²⁵ For someone at 6.6%, though, many clinicians will want to try lifestyle modifications for three to six months before adding medication, because the gap between where you are and where you need to be is relatively small.

When A1C Can’t Be Trusted and What to Use Instead

For the minority of people whose biology makes A1C unreliable, alternative markers exist. Fructosamine and glycated albumin both reflect average blood sugar, but over a shorter window of about two to three weeks rather than two to three months. They can be useful for tracking rapid changes in glucose control or for people with blood disorders that distort A1C readings.²⁶ Glycated albumin in particular has been flagged as a better marker of post-meal glucose spikes, which A1C tends to smooth over.²⁷

These alternative tests aren’t routinely ordered for everyone, but if you have iron-deficiency anemia, a hemoglobin variant, chronic kidney disease, or recent blood loss or transfusion, asking your doctor whether A1C is the right test for you is a reasonable move. A borderline result like 6.6% deserves confidence in its accuracy before it drives treatment decisions.

How A1C Testing Became Standardized

If you’ve had A1C measured at different labs and wondered whether the numbers are truly comparable, that concern has a history behind it. Following the landmark Diabetes Control and Complications Trial in 1993, which cemented A1C as the gold-standard marker for diabetes management, an international effort to standardize the assay got underway. The International Federation of Clinical Chemistry eventually established a reference measurement system, and a unified reporting approach was agreed upon.²⁸ Today, labs in the U.S. report A1C as a percentage under the National Glycohemoglobin Standardization Program, while many countries outside the U.S. also report in millimoles per mole. A result of 6.6% corresponds to about 49 mmol/mol, so if you see that figure on a lab report from another country, it’s the same reading expressed differently.

Standardization has improved inter-lab consistency, but it hasn’t eliminated it. Small differences between assay methods still exist, which is another reason a single borderline result shouldn’t carry too much diagnostic weight on its own. If you test at 6.6% at one lab and 6.3% at another a week later, neither lab necessarily made an error. The biological and analytical variability of the test can account for differences of a few tenths of a percentage point.